LC
PRAX icon

Lindbrook Capital’s Praxis Precision Medicines PRAX Stock Holding History

Lindbrook Capital’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11
Closed -$847 – 2904
2024
Q4 		$847 Hold
11
– – ﹤0.01% 2515
2024
Q3 		$633 Buy
+11
New +$594 ﹤0.01% 2608
2022
Q3 		– Sell
-8
Closed – – 2850
2022
Q2 		$0 Hold
8
– – ﹤0.01% 2705
2022
Q1 		$1K Buy
8
+6
+300% +$1.23K ﹤0.01% 2327
2021
Q4 		$1K Hold
2
– – ﹤0.01% 1973
2021
Q3 		$0 Buy
+2
New +$543 ﹤0.01% 1971

Other funds holding PRAX

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Lindbrook Capital's PRAX Position: Q1 2025 in Review

Lindbrook Capital sold out of Praxis Precision Medicines (PRAX) in Q1 2025, closing a stake of 11 shares — an estimated $847 sold.

Lindbrook Capital first reported a position in PRAX in Q3 2021 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 150 funds tracked by Wall St. Rank hold PRAX as of Q1 2025.

  • Lindbrook Capital reported no remaining Praxis Precision Medicines position as of Q1 2025 after selling out during the quarter.
  • Lindbrook Capital sold 11 Praxis Precision Medicines shares in Q1 2025, an estimated $847.
  • Lindbrook Capital first reported a position in Praxis Precision Medicines in Q3 2021 and held it in 6 quarters.
  • Lindbrook Capital's Praxis Precision Medicines position peaked at $1K in Q1 2022.
  • 150 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.